05/12/09 - 03:12 PM EDT
Bristol announces it will reaffirm its earnings guidance, and Glaxo acquires a 16% stake in South African firm Aspen Pharmacare.
05/11/09 - 05:26 PM EDT
AstraZeneca's blood-thinner outperforms Plavix in a late-stage trial, and Baxter's heparin is being investigated, according to a report.
05/08/09 - 05:04 PM EDT
AT&T is reportedly close to a $2.5 billion deal to buy pieces of Alltel Corp. from Verizon.
05/07/09 - 06:35 PM EDT
Widely held semiconductor stocks get a blistering, and Nvidia swings to a loss.
05/07/09 - 06:26 PM EDT
Google's CEO says he doesn't plan to resign from Apple's board despite a federal antitrust investigation.
05/06/09 - 06:08 PM EDT
GlaxoSmithKline is divesting its U.S. rights to Wellbutrin, sales of which have slipped 70%, as part of its strategy to reshape its U.S. business.
05/06/09 - 06:03 PM EDT
Genentech says the FDA has granted accelerated approval of its drug Avastin to treat a type of brain cancer.
05/06/09 - 05:30 PM EDT
Investors dunk Intel in the red, and Atmel gets downgraded amid disappointing quarterly sales.
05/05/09 - 06:17 PM EDT
Microsoft reportedly follows through on cuts announed in January.
05/04/09 - 03:32 PM EDT
Chip stocks are leading the tech sector higher, with Intel and AMD among the biggest winners.